| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Interest income: |
| Interest income on loans | 218.0 | 156.8 | 140.5 | 95.4 | 69.8 | 47.5 | 39.5 | 35.2 |
| Interest income on investments | | | | | | 3.8 | 3.8 | 3.2 |
| | 236.1 | 170.4 | 149.8 | 103.5 | 76.2 | 51.6 | 43.4 | 38.6 |
| Interest on deposits | 48.3 | 25.4 | 34.2 | 39.4 | 23.2 | 12.7 | 9.9 | 7.7 |
| Total interest expense | 96.9 | 46.4 | 60.8 | 66.2 | 39.3 | 20.8 | 16.4 | 12.7 |
| Net interest income | 199.6 | 153.9 | 127.6 | 80.2 | 62.2 | 44.4 | 37.6 | 34.2 |
| Provision for loan losses | 10.9 | 8.0 | 11.4 | 2.6 | 2.4 | 4.2 | 1.2 | 1.2 |
| Net interest income after provision for loan losses | 188.7 | 145.8 | 116.2 | 77.6 | 59.8 | 40.1 | 36.4 | 33.0 |
| Deposit and loan fees | | | | | | | | 1.6 |
| Gain on sale of investments, net | 0.0 | 0.4 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 |
| Other non-interest income | 59.3 | 35.4 | 21.4 | 10.6 | 7.8 | 5.6 | 5.2 | 1.6 |
| Total non-interest income | 59.2 | 35.8 | 21.6 | 10.7 | 7.8 | 5.6 | 5.4 | 3.2 |
| Non-interest expenses | 149.4 | 117.1 | 101.0 | 58.4 | 50.2 | 36.8 | 35.1 | 30.5 |
| Pre-tax income | 68.6 | 64.6 | 36.8 | 29.9 | 17.4 | 9.0 | 6.7 | 5.6 |
| Income taxes | 14.3 | 12.4 | 6.8 | 6.1 | 3.3 | 4.1 | 1.6 | 1.5 |
| Tax rate | 20.9% | 19.2% | 18.5% | 20.4% | 18.9% | 45.8% | 24.0% | 27.1% |
| Net income | 52.9 | 52.1 | 30.0 | 23.8 | 14.1 | 4.8 | 5.1 | 4.1 |
| Net margin | 21.3% | 28.7% | 21.8% | 26.9% | 20.8% | 10.6% | 12.2% | 11.3% |
| |
| Basic EPS | $2.34 | $2.54 | $1.65 | $1.79 | $1.27 | $0.63 | $0.73 | $0.61 |
| Diluted EPS | $2.32 | $2.53 | $1.64 | $1.74 | $1.22 | $0.61 | $0.70 | $0.59 |
| |
| Shares outstanding (basic) | 22.6 | 20.5 | 18.2 | 13.3 | 11.1 | 7.7 | 7.0 | 6.7 |
| Shares outstanding (diluted) | 22.8 | 20.6 | 18.2 | 13.7 | 11.5 | 8.0 | 7.3 | 7.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |